Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000722493) titled 'Ketamine Plus Exposure Therapy For Post-Traumatic Stress Disorder (PTSD)- Open Label Pilot Study Targeting Anxiety' on July 7.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: University of Otago
Condition:
Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
Mental Health - Anxiety
Mental Health - Other mental health disorders
Intervention:
1: Oral ketamine: Week 1: Day 1 - 0.5mg/kg
day 2: 1mg/kg
day 3: 1.5mg/kg
Recruitment Status: Not Recrui...